Condition

Progression of Non-small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions6

Lead sponsors shown1

Clinical trials

2 shown

Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung CancerNCT02460367 · 2016-01-01

TERMINATED

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung CancerNCT01774578 · 2013-02-01

TERMINATED

Common interventions

DocetaxelDRUG2GemcitabineDRUG1HyperAcute®-Lung ImmunotherapyBIOLOGICAL1IndoximodDRUG1PemetrexedDRUG1Tergenpumatucel-LBIOLOGICAL1

Leading sponsors

NewLink Genetics Corporation2

Trial status mix

TERMINATED2

Phase mix

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.